5564933728 · Tillverkning av medicinska och dentala instrument och tillbehör · UMEÅ
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
The operating margin declined from 44.3 % to 34.8 % in 2025. The company’s operating margin of 34.8 % exceeded three quarters of the 141 comparable companies in its industry. The net result has been positive in three consecutive comparable periods, from 2023 to 2025. RSA Biomedical AB held cash corresponding to roughly 64.6 % of total assets at the period end.
Calculated by ArkivNord from filed annual reports. About the methodology
Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge.
Net revenue
3.9 MSEK
▼ −8%Net result
0.8 MSEK
▼ −32%Employees
2
Per the signatures in the annual report for the fiscal year ending 2025-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.
arkivnord